BioSpace News Archive

Amgen (NASDAQ: AMGN),Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier today announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in Heart Failure), the second Phase 3 clinical trial of omecamtiv mecarbil, a novel cardiac myosin activator, is open to enrollment.

The Ohio Mesothelioma Victims Center is appealing to a person in Ohio who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer or their family members to call them anytime at 800-714-0303 to make certain they understand how important it is to hire one of the nation’s most skilled attorneys to work on the victim’s compensation claim.

OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare, received an order valued at approximately $8 million to provide patient monitoring solutions and related accessories to a U.S. hospital.

The Kiss and Click Challenge is a way for people learn more about their health and to encourage people they care about to do the same.

Financial services firm Edward Jones, the first national presenting sponsor for the Alzheimer’s Association annual Walk to End Alzheimer’s®, raised $3.3 million in 2018 through its 3,578 teams across the country.

Jeffrey Nau, Ph.D., M.M.S, President and CEO, is scheduled to present a corporate overview at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27th, 2019 at 1:30pm EST in New York.

MPM Capital, a life-sciences venture capital firm investing in early-stage therapeutics companies, announced the closing of its seventh venture fund, BioVentures 2018.

Intrexon Corporation, a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, announced it will release fourth quarter 2018 financial results after the market closes on Thursday, February 28th, 2019.

Former Sanofi U.S. Chairman to provide guidance and assistance to ProMIS business development strategies and partnering plans

Save the date for Swedish Orphan Biovitrum AB Capital Markets Day on 14 May 2019.